Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$725,226
+$98,420 QoQ
Shares Held
2,882
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,849
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LONGFELLOW INVESTMENT MANAGEMENT CO LLC holds $15,257,888 across 7 Drug Manufacturers - General names. ABBV ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
301,435 | $7,258,554 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
100,282 | $5,778,248 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,257 | $804,024 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,882 | $725,226 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,217 | $659,115 | |
| 6 | LLY |
ELI LILLY & Co
|
15 | $17,991 | |
| 7 | JNJ |
Johnson & Johnson
|
58 | $14,730 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $725,226 | 2,882 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $626,806 | 2,882 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $658,508 | 2,882 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $920,139 | 3,974 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $737,653 | 3,974 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $832,632 | 3,974 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $944,653 | 5,316 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,116,749 | 5,655 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $964,285 | 5,622 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,013,204 | 5,564 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,098,117 | 7,086 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,056,239 | 7,086 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,285,324 | 9,540 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,458,554 | 9,152 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,479,054 | 9,152 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,228,289 | 9,152 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,401,720 | 9,152 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,483,630 | 9,152 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,657,973 | 12,245 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,320,868 | 12,245 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,379,276 | 12,245 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,194,268 | 20,276 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,031,564 | 18,960 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||